Table 1.
IC50 values for inhibition of CYP17A1-mediated progesterone 17α-hydroxylation and CYP21A2-mediated progesterone 21-hydroxylation by abiraterone and its analogs
| entry | Inhibitor | Modification | CYP17A1 IC50 ± S.E. (nM) | CYP21A2 IC50 ± S.E. (nM) | CYP21A2 IC50 CYP17A1 IC50 |
|---|---|---|---|---|---|
| 1 | Abiraterone (1b) | – | 4.94 ± 0.09 | 32.4 ± 2.5 | 6.6 |
| 2 | Galeterone | – | 28.1 ± 2.3 | 77.2 ± 8.9 | 2.7 |
| 3 | 3b | 17-phenyl | >20,000 | ≥ 700 | – |
| 4 | 4 | Δ4 | 6.13 ± 0.41 | 0.70 ± 0.03 | 0.11 |
| 5 | 6b | 5α,6α-epoxide | 7.83 ± 0.92 | 42.1 ± 8.5 | 5.4 |
| 6 | 7 | Δ4, C-6 CN | 15.5 ± 2.7 | 23.9 ± 3.8 | 1.5 |
| 7 | 8 | Δ4, C-6 CONH2 | 22.8 ± 1.5 | 673 ± 90 | 29 |
| 8 | 10b | 5α-H, 6α-OH | 7.2 ± 0.32 | 234 ± 32 | 33 |
| 9 | 12b | 5α-H, 6-oxo | 12.4 ± 0.49 | 440 ± 60 | 35 |
| 10 | 13b | 5α-H, 6-oxime | 16.5 ± 2.5 | 1390 ± 120 | 84 |
| 11 | 14b | B-ring expanded lactam | 230 ± 51 | 3605 ± 1740 | 16 |